Core Laboratories N.V. (CLB)

Ariel Investments LLC lifted its position in shares of Core Laboratories Inc. (NYSE: CLB) by 25.5% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 12,976,463 shares of the oil and gas company's stock after acquiring an additional 2,634,438 shares

Fisher Asset Management LLC lowered its position in shares of Core Laboratories Inc. (NYSE: CLB) by 14.2% during the undefined quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 867,726 shares of the oil and gas company's stock after selling 143,838 shares during the

CLB benefits from long-term industry investments and strong acquisitions, though its growth is modest and vulnerable to macroeconomic and geopolitical uncertainties.

Tetra Technologies (NYSE: TTI - Get Free Report) and Core Laboratories (NYSE: CLB - Get Free Report) are both small-cap energy companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, risk, earnings, analyst recommendations, valuation, dividends and institutional ownership. Insider and Institutional Ownership 70.2% of Tetra

Campbell and CO Investment Adviser LLC acquired a new position in shares of Core Laboratories Inc. (NYSE: CLB) in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund acquired 25,831 shares of the oil and gas company's stock, valued at approximately $298,000. Campbell and CO

Envestnet Asset Management Inc. boosted its holdings in shares of Core Laboratories Inc. (NYSE: CLB) by 11.4% in the undefined quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 282,871 shares of the oil and gas company's stock after purchasing an additional

Oppenheimer Asset Management Inc. cut its holdings in shares of Core Laboratories Inc. (NYSE: CLB) by 9.0% during the undefined quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 62,951 shares of the oil and gas company's stock after selling 6,233 shares

CLB beats Q3 earnings estimates on strong Production Enhancement results. However, earnings dip y/y due to the Reservoir Description segment's weakness.

Supplier of residential thermal, comfort and security solutions, Resideo Technologies, Inc. (REZI) was the top contributor in the quarter. Shares of gold mining company, Barrick Mining Corporation (B) also jumped in the quarter on strong financial results buoyed by rising gold prices. We added Arthur J. Gallagher & Co. (AJG), the world's largest insurance broker focused on middle-market clients.

Core Laboratories Inc. (NYSE:CLB ) Q3 2025 Earnings Call October 23, 2025 8:30 AM EDT Company Participants Lawrence Bruno - Chairman of the Board, CEO, President & COO Gwendolyn Schreffler - Senior Vice President of Corporate Development & Investor Relations Chris Hill - Senior VP & CFO Conference Call Participants John Daniel - Daniel Energy Partners, LLC Presentation Operator Good day, and welcome to the Core Laboratories Q3 2025 Earnings Call. [Operator Instructions] Please note, this event is being recorded.

Core Laboratories (CLB) came out with quarterly earnings of $0.22 per share, beating the Zacks Consensus Estimate of $0.19 per share. This compares to earnings of $0.25 per share a year ago.

HOUSTON, Oct. 22, 2025 /PRNewswire/ -- Core Laboratories Inc. (NYSE: "CLB") ("Core", "Core Lab", or the "Company") reported third quarter 2025 revenue of $134,500,000. Core's operating income was $20,900,000, with earnings per diluted share ("EPS") of $0.30, all in accordance with U.S. generally accepted accounting principles ("GAAP"). Operating income, ex-items, a non-GAAP financial measure, was $16,600,000, yielding operating margins of 12%, sequential incremental margins of 48%, and EPS, ex-items, of $0.22. A full reconciliation of non-GAAP financial measures is included in the attached financial tables.

CLB is set to post Q3 earnings amid volatile oil markets, with estimates hinting at lower revenues and profit declines.

Core Laboratories (CLB) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Core Laboratories (CLB) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.